139 related articles for article (PubMed ID: 6821487)
1. Successful treatment of extremely brittle, insulin-dependent diabetes with a novel subcutaneous insulin pump regimen.
Nathan DM
Diabetes Care; 1982; 5(2):105-10. PubMed ID: 6821487
[TBL] [Abstract][Full Text] [Related]
2. Brittle diabetes revisited: a description of erratic and difficult-to-control diabetes in an elderly woman with Type 1 diabetes.
Newman C; Dinneen SF
Diabet Med; 2020 Oct; 37(10):1777-1780. PubMed ID: 31004371
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)].
Talaulicar M; Willms B
Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348
[TBL] [Abstract][Full Text] [Related]
5. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
Dogan ADA; Jørgensen UL; Gjessing HJ
J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
[No Abstract] [Full Text] [Related]
6. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
Hildebrandt P
Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
[TBL] [Abstract][Full Text] [Related]
8. Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").
Campbell IW; Kritz H; Najemnik C; Hagmueller G; Irsigler K
Diabetes Res; 1984 Jul; 1(2):83-8. PubMed ID: 6442226
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of brittle diabetic patients unresponsive to optimized subcutaneous insulin therapy (continuous subcutaneous insulin infusion).
Pickup J; Williams G; Johns P; Keen H
Diabetes Care; 1983; 6(3):279-84. PubMed ID: 6409572
[No Abstract] [Full Text] [Related]
10. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
[TBL] [Abstract][Full Text] [Related]
11. Diabetics treated with continuous subcutaneous insulin infusion pumps.
Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J
Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015
[TBL] [Abstract][Full Text] [Related]
12. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
[TBL] [Abstract][Full Text] [Related]
13. Insulin infusion for diabetic children.
Boulton J; Penfold J
Med J Aust; 1981 Oct; 2(9):474-6. PubMed ID: 6798379
[TBL] [Abstract][Full Text] [Related]
14. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care.
Bending JJ; Pickup JC; Keen H
Am J Med; 1985 Dec; 79(6):685-91. PubMed ID: 3934967
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
Pickup J; Keen H
Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953
[TBL] [Abstract][Full Text] [Related]
16. [Continuous subcutaneous insulin infusion].
Ito H; Kanatsuka A
Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
[No Abstract] [Full Text] [Related]
17. Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy.
Koivisto VA; Tronier B
Diabetes Care; 1983; 6(5):436-40. PubMed ID: 6400702
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
19. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to preventing diabetic ketoacidosis in a patient treated with an insulin pump.
Phillips BD; Aurand LA; Bedwell MM; Levy JR
Diabetes Care; 2003 Oct; 26(10):2960-1. PubMed ID: 14514614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
